Urologic Oncologist/Robotic Urologic Surgeon

City of Hope; Santa Clarita (CA); On-site; USD 350,000 - 425,000; Full time

Benefits offered by this job

Relocation assistance may be available

Excellent benefits package

Generous retirement contribution plan

Job summary

City of Hope is seeking a full-time Urologic Oncologist/Robotic Urologic Surgeon to join the Division of Urology and Urologic Oncology in Santa Clarita/Antelope Valley, CA. The role emphasizes patient-centered care within a multidisciplinary team, with access to da Vinci robotic systems and a focus on clinical trials and academic activities.

The position offers 90–95% clinical duties, potential faculty involvement in the Urologic Oncology Fellowship, and a competitive base salary with relocation

Qualifications

• Excellent clinical skills and desire to build a practice and think programmatically.
• MD/DO or equivalent, fellowship-trained robotic surgery/urology, and board certified and/or eligible.
• Academic record consistent with appointment as Assistant (new Fellow) to Clinical Professor
• Have or eligible to obtain appropriate license to practice
• Possession of, or eligibility for, unrestricted medical license in the State of California

Responsibilities

• Provide patient-centered care in a busy Urologic Oncology and Robotic Surgery practice with an established multidisciplinary team.
• Contribute to development of clinical trials and research studies.
• Pursue academic appointments and participate in educational activities.
• Opportunity to serve as faculty for the Urologic Oncology Fellowship program and integrate with the division.

Skills

Clinical skills

Education

MD/DO or equivalent

Fellowship-trained robotic surgery/urology

Medical license in CA or eligible

Job description

Urologic Oncologist/Robotic Urologic Surgeon

Santa Clarita, California, United States (on-site)

Description

Join one of the top cancer centers in the nation! Our rapidly expanding, nationally recognized cancer institute seek to hire a full-time, fellowship-trained Urologic Oncologist /Robotic Urologic Surgeon to join City of Hope in Antelope Valley (Lancaster, CA). We are seeking research and mission- minded physicians as every discovery we make and every new treatment we create gives people the chance to live longer, better, and more fully.

We are seeking a Urologic Oncologist /Robotic Urologic Surgeon to join the Division of Urology and Urologic Oncology team at City of Hope who will provide patient-centered care in collaboration with an established team of world class, nationally recognized physicians and healthcare professionals.

• Full-time position reporting to the Chief of the Division of Urology and Urologic Oncology
• Provide patient-centered care in collaboration with an established multidisciplinary team of physicians and nurses at a state-of-the-art outpatient clinic facility
• Busy Urologic Oncology, Robotic Surgery and General Urology practice with established and expanding referral base
• Wonderful colleagues, within an expansive Division of Urology & Urologic Oncology. Collaborative team environment with APP support available to facilitate care within your practice. Would be joining 5 other urologists and 1 APP at this network location and a total of 20 urologists in the Division.
• Opportunity to serve as a faculty for our Urologic Oncology Fellowship program
• Provide primarily 90-95% clinical responsibilities with access to da Vinci DV5 and SP robots
• Contribute to the development of clinical trials and research studies
• Pursue academic appointments and participate in educational activities
• Excellent benefits package, including a generous retirement contribution plan
• Relocation assistance may be available
• Base Salary Range: $350,000 - $425,000 (Assistant Clinical to Clinical Professor levels). The range listed is exclusively for base compensation for full-time employment and does not include incentive compensation or benefits. Actual compensation will be adjusted for experience, training, hospital/community need and other factors.

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope TM.

City of Hope is an equal opportunity employer.

Qualifications

• Excellent clinical skills and desire to build a practice and think programmatically
• Applicants must have an M.D., D.O. or equivalent degree, fellowship- trained robotic surgery/urology, and be Board certified and/or eligible.
• Academic record consistent with appointment as an Assistant (new Fellow) to Clinical Professor
• Have or eligible to obtain appropriate license to practice
• Possession of, or eligibility for, unrestricted medical license in the State of California

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope TM, a wholly owned s ...